Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Quad Tablet
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Analysis of Crushed and Whole Tablet Genvoya
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 24, 2018
Lead Product(s) : Quad Tablet
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable